[HTML][HTML] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC cancer, 2006 - Springer
Background Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation of …

[PDF][PDF] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - Citeseer
Background: Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - search.ebscohost.com
Background: Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

[PDF][PDF] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - cyberleninka.org
Background: Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

[HTML][HTML] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh… - BMC …, 2006 - bmccancer.biomedcentral.com
Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation of
prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

[PDF][PDF] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - researchgate.net
Background: Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC cancer, 2006 - pubmed.ncbi.nlm.nih.gov
Background Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

[PDF][PDF] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - scienceopen.com
Background: Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.

TL Larkins, M Nowell, S Singh, GL Sanford - BMC Cancer, 2006 - europepmc.org
Background Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …